FDA Drug recall D-0298-2026
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceu…
- FDA Drug
- Class II
- ongoing
- Published 2026-02-04
On 2026-02-04 the FDA classified a Class II recall of INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceu… by Sato Pharmaceutical, citing failed Disintegration Specifications: above the time expected.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0298-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2025-12-19 |
| Published | 2026-02-04 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sato Pharmaceutical |
| Distribution | CA, HI |
Product
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Reason
Failed Disintegration Specifications: above the time expected.
Identifiers
| ndc | 49873-402-01 |
|---|---|
| code_info | Lot#: PWXT, Exp 1/31/2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0298-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.